KENFOX IP & Law Office > Articles posted by Vu Thu Uyen (Page 2)

KENFOX Partner Makes Waves at International Trademark & Brand Festival in China

Mr. Nguyen Vu Quan, a Partner at KENFOX, recently attended the prestigious 14th China International Trademark & Brand Festival (CTF) held in Xi'an from November 22-25, 2024. CTF is a leading international event in the trademark and brand industry, renowned for its high standards and extensive reach. Since its inception in 2005, CTF has been hosted in major Chinese cities including Shanghai, Qingdao, and Chengdu, attracting over 4,000 participants annually, including representatives from over 30 countries. Mr. Quan actively engaged in sub-forums and salons, posing insightful questions to speakers on a range of critical topics. His inquiries included: Best practices for IPR...

Continue reading

KENFOX Partner Presents on Southeast Asian Medical Device Patent Trends in Suzhou

Suzhou, China – Mr. Nguyen Vu Quan, IP Attorney and Partner at KENFOX IP & Law Office delivered a keynote presentation on "New Developments in Examination and Enforcement of Medical Device Patents in Southeast Asia" at the seminar in Suzhou on 19 November 2024. The presentation was part of a "Intellectual Property Services for High-Quality Industrial Development" salon series held at the Jiangsu Center for Patent Examination Cooperation in Suzhou. The event, co-hosted by the China National Intellectual Property Administration (CNIPA) and the Jiangsu Provincial Intellectual Property Office, focused on promoting high-quality development in the biopharmaceutical industry. Sharing at the seminar, Mr....

Continue reading

Giving presentation about “Risks of Intellectual Property Infringement on Cross-Border E-commerce Platforms in Southeast Asia and Responding Strategies” in Wujiang District, China

Wujiang District, China – Mr. Nguyen Vu Quan, an IP Attorney and Partner at KENFOX IP & Law Office, recently delivered a compelling presentation on the “Risks of Intellectual Property Infringement on Cross-Border E-commerce Platforms in Southeast Asia and Responding Strategies“. ...

Continue reading

“Fabrilcar” vs. “FABRICA” and “FABRICAIR”: How to successfully appeal a trademark refusal in Vietnam?

Vietnam – On 16/10/2024, the IP Offfice of Vietnam (“IP VIETNAM“) issued a Decision on acceptance of IR No. 1470915 for the mark “Fabrilcar” in the name of Aspöck Systems GmbH, withdrawing its provisional refusal decision and terminating a lengthy 4-year appeal process. This is a great victory for our client, Aspöck Systems GmbH, an Austrian company that specializes in developing and manufacturing lighting systems for vehicles, founded in September 1977....

Continue reading

New Developments in Patent Examination and Enforcement in the Field of Medical Devices in Southeast Asia

The medical device sector in Southeast Asia is witnessing unprecedented innovation, accelerating development and reshaping healthcare across the region. This progress, however, introduces new challenges for patent protection, making it essential for inventors and companies to stay informed on evolving regulations and enforcement mechanisms....

Continue reading

Second Medical Use Patents: Promoting Development or Hindering the Pharmaceutical Industry in Southeast Asia?

Download The pharmaceutical landscape in Southeast Asia is undergoing a dynamic shift, with second medical use claims emerging as a crucial battleground. These claims, which protect the use of a known medical substance or device for a new therapeutic application, are gaining traction, but not without controversy. KENFOX IP & Law Office provides you with the importance and contentious nature of second medical use claims in Southeast Asia, examining the varying approaches across the region. Second Medical Use Claims: What They Matter? Developing new drugs and therapies requires significant investment in research and development (R&D). Second medical use claims provide pharmaceutical companies with...

Continue reading

Joint Liability Confirmed in Thai Patent Infringement Case

Facts Thailand - In January 2024, the Court of Appeal for Specialized Cases upheld a ruling that found two local pharmaceutical companies, Unisun and Medline, jointly liable for infringing H. Lundbeck A/S's patent for antidepressant escitalopram. The court confirmed the lower court's finding that the companies manufactured, sold, and distributed the drug in Thailand without authorization. The companies were ordered to pay Lundbeck 106,500 Danish Krone (approximately US$15,500) in damages, plus legal costs and court fees. The case began in June 2020, when Lundbeck initiated legal action against Unisun and Medline for allegedly manufacturing, selling, and distributing escitalopram in Thailand without authorization....

Continue reading

Exploring Collaboration Opportunities in Intellectual Property: KENFOX and Sha Patent and Trademark Firm

Today, 01 November 2024, KENFOX IP & Law Office has successfully arranged a Zoom meeting with a partner from Japan. Participating the meeting is Mr. Hakucho Sha, Co-founder Managing partner of Sha Patent and Trademark Firm and Mr. Quan, IP Manager and Ms. Hong and Ms. Nga, senior associates from KENFOX IP & Law Office in Vietnam....

Continue reading

Re-Registration Of Chinese Patents In Cambodia: What Should Be Noted?

Cambodia and China entered into the Memorandum of Understanding on Bilateral Cooperation on Intellectual Property (“MOU”). The Cambodian Ministry of Industry and Handicrafts (“MIH”) adopted Prakas (Declaration) No. 080 MIH/2018 dated 27 March 2018 on the re-registration of Chinese patent in Cambodia. This MOU is valid for 5 years from the date of signing. It has been renewed recently....

Continue reading